BLUELINX HOLDINGS INC (BXC) Fundamental Analysis & Valuation

NYSE:BXC • US09624H2085

59.94 USD
-2.18 (-3.51%)
At close: Mar 6, 2026
59.94 USD
0 (0%)
After Hours: 3/6/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This BXC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Taking everything into account, BXC scores 4 out of 10 in our fundamental rating. BXC was compared to 47 industry peers in the Trading Companies & Distributors industry. BXC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BXC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. BXC Profitability Analysis

1.1 Basic Checks

  • In the past year BXC was profitable.
  • BXC had a positive operating cash flow in the past year.
  • Each year in the past 5 years BXC has been profitable.
  • Each year in the past 5 years BXC had a positive operating cash flow.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • With a Return On Assets value of 0.01%, BXC perfoms like the industry average, outperforming 40.43% of the companies in the same industry.
  • BXC has a Return On Equity of 0.04%. This is in the lower half of the industry: BXC underperforms 61.70% of its industry peers.
  • BXC's Return On Invested Capital of 1.69% is on the low side compared to the rest of the industry. BXC is outperformed by 65.96% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BXC is below the industry average of 9.12%.
Industry RankSector Rank
ROA 0.01%
ROE 0.04%
ROIC 1.69%
ROA(3y)2.18%
ROA(5y)9.78%
ROE(3y)5.3%
ROE(5y)29.53%
ROIC(3y)4.86%
ROIC(5y)14.09%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.01%, BXC is doing worse than 61.70% of the companies in the same industry.
  • In the last couple of years the Profit Margin of BXC has declined.
  • Looking at the Operating Margin, with a value of 1.02%, BXC is doing worse than 68.09% of the companies in the same industry.
  • BXC's Operating Margin has declined in the last couple of years.
  • BXC's Gross Margin of 15.29% is on the low side compared to the rest of the industry. BXC is outperformed by 82.98% of its industry peers.
  • BXC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.02%
PM (TTM) 0.01%
GM 15.29%
OM growth 3Y-51.87%
OM growth 5Y-23.7%
PM growth 3Y-89.63%
PM growth 5Y-69.05%
GM growth 3Y-6.52%
GM growth 5Y-0.17%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. BXC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BXC is destroying value.
  • The number of shares outstanding for BXC has been reduced compared to 1 year ago.
  • The number of shares outstanding for BXC has been reduced compared to 5 years ago.
  • Compared to 1 year ago, BXC has a worse debt to assets ratio.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • BXC has an Altman-Z score of 3.36. This indicates that BXC is financially healthy and has little risk of bankruptcy at the moment.
  • BXC has a Altman-Z score (3.36) which is in line with its industry peers.
  • BXC has a debt to FCF ratio of 18.81. This is a negative value and a sign of low solvency as BXC would need 18.81 years to pay back of all of its debts.
  • BXC has a Debt to FCF ratio (18.81) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.96 indicates that BXC is somewhat dependend on debt financing.
  • BXC has a Debt to Equity ratio (0.96) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 18.81
Altman-Z 3.36
ROIC/WACC0.17
WACC9.92%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • BXC has a Current Ratio of 4.66. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.66, BXC belongs to the top of the industry, outperforming 95.74% of the companies in the same industry.
  • A Quick Ratio of 3.12 indicates that BXC has no problem at all paying its short term obligations.
  • BXC's Quick ratio of 3.12 is amongst the best of the industry. BXC outperforms 95.74% of its industry peers.
Industry RankSector Rank
Current Ratio 4.66
Quick Ratio 3.12
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BXC Growth Analysis

3.1 Past

  • BXC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -85.11%.
  • The earnings per share for BXC have been decreasing by -35.32% on average. This is quite bad
  • BXC shows a small growth in Revenue. In the last year, the Revenue has grown by 0.05%.
  • BXC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.94% yearly.
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-12.77%
Revenue growth 5Y-0.94%
Sales Q2Q%0.73%

3.2 Future

  • BXC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 85.45% yearly.
  • BXC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.38% yearly.
EPS Next Y-41.26%
EPS Next 2Y85.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.9%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

3

4. BXC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 63.09, which means the current valuation is very expensive for BXC.
  • Compared to the rest of the industry, the Price/Earnings ratio of BXC indicates a slightly more expensive valuation: BXC is more expensive than 63.83% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.29, BXC is valued quite expensively.
  • A Price/Forward Earnings ratio of 107.41 indicates a quite expensive valuation of BXC.
  • Based on the Price/Forward Earnings ratio, BXC is valued a bit more expensive than the industry average as 65.96% of the companies are valued more cheaply.
  • The average S&P500 Price/Forward Earnings ratio is at 24.57. BXC is valued rather expensively when compared to this.
Industry RankSector Rank
PE 63.09
Fwd PE 107.41
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BXC is valued a bit cheaper than the industry average as 68.09% of the companies are valued more expensively.
  • BXC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BXC is cheaper than 85.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.36
EV/EBITDA 10.3
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

  • BXC's earnings are expected to grow with 85.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y85.45%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BXC Dividend Analysis

5.1 Amount

  • BXC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BXC Fundamentals: All Metrics, Ratios and Statistics

BLUELINX HOLDINGS INC

NYSE:BXC (3/6/2026, 8:04:00 PM)

After market: 59.94 0 (0%)

59.94

-2.18 (-3.51%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-24
Earnings (Next)04-27
Inst Owners100.59%
Inst Owner Change1.62%
Ins Owners2.21%
Ins Owner Change0.01%
Market Cap471.73M
Revenue(TTM)2.95B
Net Income(TTM)219.00K
Analysts77.5
Price Target78.03 (30.18%)
Short Float %6.11%
Short Ratio4.82
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.66%
Min EPS beat(2)-23.18%
Max EPS beat(2)-10.14%
EPS beat(4)1
Avg EPS beat(4)-14.28%
Min EPS beat(4)-24.67%
Max EPS beat(4)0.88%
EPS beat(8)4
Avg EPS beat(8)9.11%
EPS beat(12)7
Avg EPS beat(12)11.85%
EPS beat(16)10
Avg EPS beat(16)12.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-2.07%
Max Revenue beat(2)0.69%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)0.69%
Revenue beat(8)3
Avg Revenue beat(8)-0.71%
Revenue beat(12)3
Avg Revenue beat(12)-2.91%
Revenue beat(16)5
Avg Revenue beat(16)-1.52%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.05%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.9%
Valuation
Industry RankSector Rank
PE 63.09
Fwd PE 107.41
P/S 0.16
P/FCF 14.36
P/OCF 7.89
P/B 0.76
P/tB 1.02
EV/EBITDA 10.3
EPS(TTM)0.95
EY1.58%
EPS(NY)0.56
Fwd EY0.93%
FCF(TTM)4.17
FCFY6.96%
OCF(TTM)7.6
OCFY12.67%
SpS375.35
BVpS78.44
TBVpS58.88
PEG (NY)N/A
PEG (5Y)N/A
Graham Number40.95
Profitability
Industry RankSector Rank
ROA 0.01%
ROE 0.04%
ROCE 2.25%
ROIC 1.69%
ROICexc 2.37%
ROICexgc 2.83%
OM 1.02%
PM (TTM) 0.01%
GM 15.29%
FCFM 1.11%
ROA(3y)2.18%
ROA(5y)9.78%
ROE(3y)5.3%
ROE(5y)29.53%
ROIC(3y)4.86%
ROIC(5y)14.09%
ROICexc(3y)7.81%
ROICexc(5y)17.95%
ROICexgc(3y)8.79%
ROICexgc(5y)19.65%
ROCE(3y)6.47%
ROCE(5y)18.75%
ROICexgc growth 3Y-56.47%
ROICexgc growth 5Y-25.31%
ROICexc growth 3Y-57.61%
ROICexc growth 5Y-26.66%
OM growth 3Y-51.87%
OM growth 5Y-23.7%
PM growth 3Y-89.63%
PM growth 5Y-69.05%
GM growth 3Y-6.52%
GM growth 5Y-0.17%
F-Score5
Asset Turnover1.91
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 18.81
Debt/EBITDA 8.51
Cap/Depr 67.49%
Cap/Sales 0.91%
Interest Coverage 0.64
Cash Conversion 85.42%
Profit Quality 15000.5%
Current Ratio 4.66
Quick Ratio 3.12
Altman-Z 3.36
F-Score5
WACC9.92%
ROIC/WACC0.17
Cap/Depr(3y)85.86%
Cap/Depr(5y)87.75%
Cap/Sales(3y)1.05%
Cap/Sales(5y)0.86%
Profit Quality(3y)5219.88%
Profit Quality(5y)3165.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
EPS Next Y-41.26%
EPS Next 2Y85.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-12.77%
Revenue growth 5Y-0.94%
Sales Q2Q%0.73%
Revenue Next Year3.9%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.73%
EBIT growth 3Y-58.02%
EBIT growth 5Y-24.42%
EBIT Next Year80.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.11%
FCF growth 3Y-55.16%
FCF growth 5Y-8.53%
OCF growth 1Y-29.81%
OCF growth 3Y-46.94%
OCF growth 5Y1.68%

BLUELINX HOLDINGS INC / BXC FAQ

What is the fundamental rating for BXC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BXC.


What is the valuation status of BLUELINX HOLDINGS INC (BXC) stock?

ChartMill assigns a valuation rating of 3 / 10 to BLUELINX HOLDINGS INC (BXC). This can be considered as Overvalued.


What is the profitability of BXC stock?

BLUELINX HOLDINGS INC (BXC) has a profitability rating of 3 / 10.


How financially healthy is BLUELINX HOLDINGS INC?

The financial health rating of BLUELINX HOLDINGS INC (BXC) is 6 / 10.